Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Genomic analysis and selective small molecule inhibition identifies BCL-XL as a critical survival factor in a subset of colorectal cancer

Fig. 1

Cross-cancer tumor sample analysis identified colorectal cancer as having the highest frequency of BCL2L1 amplification. a Cross-cancer alteration summary for BCL2, BCL2L1 and MCL1 based on data obtained from cBioPortal for Cancer Genomics. b Correlation between gene expression and copy number alteration of BCL2L1 in 212 colorectal cancer samples

Back to article page

Molecular Cancer

ISSN: 1476-4598